Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups
- PMID: 8253362
- DOI: 10.1016/0016-5085(93)91086-w
Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups
Abstract
Background: The precision of current prognostic models in primary biliary cirrhosis (PBC) is rather low, partly because they are based on data from just one time during the course of the disease. The aim of this study was to design a new, more precise prognostic model by incorporating follow-up data in the development of the model.
Methods: We have performed Cox regression analyses with time-dependent variables in 237 PBC patients followed up regularly for up to 11 years. The validity of the obtained models was tested by comparing predicted and observed survival in 147 independent PBC patients followed for up to 6 years.
Results: In the obtained model the following time-dependent variables independently indicated a poor prognosis: high bilirubin, low albumin, ascites, gastrointestinal bleeding, and old age. When including histological variables, cirrhosis, central cholestasis, and low immunoglobulin (Ig)M also indicated a poor prognosis. The survival predicted by the models agreed well with the survival observed in the independent PBC patients. The time-dependent models predicted better than our previously published time-fixed model.
Conclusions: Using the time-dependent Cox models, one can estimate a more precise probability of surviving the next 1, 3, or 6 months for any given patient at any time during the course of the disease. This may improve monitoring of PBC patients.
Similar articles
-
Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: a staged prognostic model.Scand J Gastroenterol. 2005 Sep;40(9):1081-9. doi: 10.1080/00365520510023215. Scand J Gastroenterol. 2005. PMID: 16211715
-
Prognosis in primary biliary cirrhosis. A review.Ital J Gastroenterol. 1991 May;23(4):222-6. Ital J Gastroenterol. 1991. PMID: 1751821 Review.
-
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.Gastroenterology. 1985 Nov;89(5):1084-91. doi: 10.1016/0016-5085(85)90213-6. Gastroenterology. 1985. PMID: 3899841 Clinical Trial.
-
Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.Hepatogastroenterology. 1997 Jul-Aug;44(16):982-9. Hepatogastroenterology. 1997. PMID: 9261586
-
Survival algorithms and outcome analysis in primary biliary cirrhosis.Semin Liver Dis. 1997 May;17(2):147-58. doi: 10.1055/s-2007-1007193. Semin Liver Dis. 1997. PMID: 9170202 Review.
Cited by
-
Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.Curr Gastroenterol Rep. 1999 Apr;1(2):95-101. doi: 10.1007/s11894-996-0006-8. Curr Gastroenterol Rep. 1999. PMID: 10980934 Review.
-
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy.Biomed Res Int. 2013;2013:139763. doi: 10.1155/2013/139763. Epub 2013 Jul 24. Biomed Res Int. 2013. PMID: 23984317 Free PMC article.
-
Azathioprine for primary biliary cirrhosis.Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD006000. doi: 10.1002/14651858.CD006000.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636817 Free PMC article.
-
Liver/spleen volume ratio as a predictor of prognosis in primary biliary cirrhosis.J Gastroenterol. 2008;43(8):632-6. doi: 10.1007/s00535-008-2202-9. Epub 2008 Aug 17. J Gastroenterol. 2008. PMID: 18709486
-
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.Gut. 1996 Apr;38(4):610-5. doi: 10.1136/gut.38.4.610. Gut. 1996. PMID: 8707097 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources